Peptide History intermediate
History of Peptide Vaccine Development
Milestones in peptide vaccine technology from epitope mapping to neoantigen vaccines.
By Encyclopeptide Editorial | 1 min read
vaccine epitope neoantigen history
Overview
Peptide vaccines have evolved from simple epitope-based approaches to sophisticated multi-epitope and personalized designs.
Key Milestones
- 1980s: T-cell epitope identification
- 1990s: First cancer peptide vaccine trials
- 1995: HLA-restricted epitope peptides
- 2000s: Multi-epitope vaccine designs
- 2010s: Neoantigen discovery platforms
- 2020s: Personalized mRNA-peptide vaccines
Advantages
Safety, stability, rapid design, and specificity make peptide vaccines attractive for infectious disease and oncology.
Current Applications
HPV, melanoma, and personalized cancer vaccines represent the most advanced peptide vaccine programs.
References
- Source: ENCP Peptide Database
- Category: Peptide History
Test Your Knowledge
Reinforce what you learned about History of Peptide Vaccine Development with interactive quizzes on Wikipept.
Take a Quiz on Wikipept